[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336868-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336868-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pregnancy-associated-triple-negative-breast-cancer-a-case-report-and-literature-review","Pregnancy-associated triple-negative breast cancer - A case report and literature review","","Incidence of pregnancy-associated breast cancer (PABC) is relatively low yet rising, and pregnancy’s unique physiology makes diagnosis and systemic therapy challenging due to risk to both fetus and mother. A 33-year-old woman with a left breast mass during the second pregnancy at 23+4 weeks was diagnosed with triple-negative breast cancer after biopsy confirmation. Pregnancy was terminated, followed by neoadjuvant epirubicin plus docetaxel, then modified radical mastectomy and subsequent radiotherapy/chemotherapy. Disease-free survival was 3 months with later local metastasis, after which treatment continued with good general condition.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pregnancy-associated-triple-negative-breast-cancer-a-case-report-and-literature-review/336868/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pregnancy-associated-triple-negative-breast-cancer-a-case-report-and-literature-review/336868.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is pregnancy-associated breast cancer (PABC)?","Question",{"text":63,"@type":64},"PABC is newly diagnosed breast cancer during pregnancy or within one year after delivery. It is rare but has increased in recent years.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the diagnosis confirmed in the reported case?",{"text":68,"@type":64},"A breast ultrasound identified a left breast mass, and the diagnosis was confirmed by a puncture biopsy of the left breast mass.",{"name":70,"@type":61,"acceptedAnswer":71},"What treatment sequence was used after termination of pregnancy?",{"text":72,"@type":64},"After multidisciplinary discussion, pregnancy was terminated. The patient then received standard triple-negative breast cancer treatment: neoadjuvant epirubicin plus docetaxel, followed by modified radical mastectomy, and then radiotherapy and chemotherapy in sequence.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336868,1790453791,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":97,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","®  \n Clinical Case Report   \nPregnancy-associated triple-negative breast cancer  \nA case report and literature review  \nWeichao Bao, BMa , Xiaolin Ma, MDb , Yuan Xue, BMa , Xin Zou, BMa , Ying Guo, MDc ,*  \n\n| Abstract\u003Cbr>Rationale: The incidence of pregnancy-associated breast cancer (PABC) is relatively low, but it has been increasing in recent years. The onset of PABC causes serious harm to the fetus and the mother due to the unique physiological characteristics of pregnancy, which poses a particular challenge to clinicians. This article reports a case of pregnancy-associated triple-negative breast cancer and describes the patient characteristics and systematic treatment of this type of breast cancer.\u003Cbr>Patient concerns: A 33-year-old woman was admitted to hospital with a left breast mass that had appeared more than a year earlier. She was a second-time pregnant woman with a single live intrauterine fetus at 23 + 4 weeks of gestation. During the examination of the left breast, a 6 by 8 cm sized mass can be observed on the upper outer quadrant.\u003Cbr>Diagnosis: Pregnancy-associated triple-negative breast cancer.\u003Cbr>Intervention: The patient underwent a breast ultrasound which showed a left breast mass and the diagnosis was confirmed by a puncture biopsy of the left breast mass. The pregnancy was terminated after multidisciplinary discussion, taking into account the wishes of the patient and her family. After termination of the pregnancy, all treatments were given according to the standard triple-negative breast cancer (TNBC) treatment protocol. The patient was treated with neoadjuvant chemotherapy with epirubicinin combination with docetaxel (TE) in cycles of 21 days. After 3 cycles of TE, a modified radical mastectomy for left breast cancer was performed, and the appropriate radiotherapy and chemotherapy treatments were carried out in sequence.\u003Cbr>Outcomes: After the surgery, the disease-free survival for the patient was 3 months until local metastases were diagnosed. Thus the radiotherapy and chemotherapy were carried out, and then the patient was in good general condition with no recurrence or metastases.\u003Cbr>Lessons: Clinicians need more research into the diagnosis, treatment and prognosis of PABC. Improving the rate of early diagnosis and using standardized and individualized comprehensive treatment plans will minimize fetal damage and improve survival and quality of life for patients.\u003Cbr>Abbreviations: ER = estrogen receptor, HER2 = human epidermal receptor-2, PABC = pregnancy-associated breast cancer, PR = progesterone receptor, TNBC = triple-negative breast cancer. |\n| --- |\n| Keywords: case report, PABC, systematic treatment, TNBC |\n\n1. Introduction  \nBreast cancer is one of the most common invasive cancers in women and is the second cancer frequently occurring worldwide of newly-diagnosed cancers.[1,2] Pregnancy-associated breast cancer (PABC) is defined as newly diagnosed breast cancer during pregnancy or within 1 year of delivery.[3] Although PABC is relatively rare, its incidence has increased in recent years. The impact of systemic therapy on the fetus presents a particular  \nchallenge to clinicians. Compared with common breast cancer, PABC is characterized by a low rate of early detection and poor prognosis. PABC is usually diagnosed in the middle to late stages,[4] of which the onset can be extremely detrimental to the fetus and the mother. In order to detect and diagnose PABC in time and standardize the treatment, we retrospectively analyzed 1 case of PABC admitted to our hospital, and the case report is as follows.  \nThe authors have no funding and conflicts of interest to disclose.  \nData sharing not applicable to this article as no datasets were generated or analyzed during the current study.  \nThe study was approved by the Ethical Committees of the Affiliated Hospital of Shandong Second Medical University. Information revealing the subject’s identity was avoided. Written and signed informed consent was obtai","cbCaikKax1NaRqJY","https://ap.wps.com/l/cbCaikKax1NaRqJY","pdf",731373,"English","# Abstract\n# Introduction\n# Case presentation","[{\"question\":\"What is pregnancy-associated breast cancer (PABC)?\",\"answer\":\"PABC is newly diagnosed breast cancer during pregnancy or within one year after delivery. It is rare but has increased in recent years.\"},{\"question\":\"How was the diagnosis confirmed in the reported case?\",\"answer\":\"A breast ultrasound identified a left breast mass, and the diagnosis was confirmed by a puncture biopsy of the left breast mass.\"},{\"question\":\"What treatment sequence was used after termination of pregnancy?\",\"answer\":\"After multidisciplinary discussion, pregnancy was terminated. The patient then received standard triple-negative breast cancer treatment: neoadjuvant epirubicin plus docetaxel, followed by modified radical mastectomy, and then radiotherapy and chemotherapy in sequence.\"}]","Pregnancy-associated triple-negative breast cancer - A case report and literature review | PDF",1790016919,13,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24f4041ed2d87a8fee36b67658a36f0e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b410d72f83eef5ec45caaa94a736a5bb.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed33f4930c0b109786ad245208f6b4d0.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c65da6d4f21f1620259b7113151042f.webp",980,1306]